HSulf1 and palbociclib exert synergistic antitumor effects on RBpositive triplenegative breast cancer. Chen F, Zhang Z, Yu Y, Liu Q, et al. Int J Oncol 2020 May 4. doi: 10.3892/ijo.2020.5057.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen F, Zhang Z, Yu Y, Liu Q, et al. HSulf1 and palbociclib exert synergistic antitumor effects on RBpositive triplenegative breast cancer. Int J Oncol 2020 May 4. doi: 10.3892/ijo.2020.5057.
PMID: 32377705